Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sichen Li

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2014
Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomasSichen Li, Reshmi Chowdhury, Fei Liu, et al.
Cell Reports|March 23, 2026
Multi-omics analysis reveals NSUN2-mediated m5C methylation of DOCK9 regulating vascular stability in brain arteriovenous malformationsGanglei Li, Hongfei Zhang, Biyun Wang, et al.
Journal of Neuro-Oncology|March 7, 2019
SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activationFei Liu, Christopher D Cox, Reshmi Chowdhury, et al.
Neuro-Oncology|March 15, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Julia Selfridge, Reema R Mody, et al.
Cell Metabolism|July 21, 2015
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR SignalingXudong Fu, Randall M Chin, Laurent Vergnes, et al.
Journal of the National Cancer Institute|September 5, 2012
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomasArthur P Chou, Reshmi Chowdhury, Sichen Li, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2014
Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomasSichen Li, Reshmi Chowdhury, Fei Liu, et al.
Cell Reports|March 23, 2026
Multi-omics analysis reveals NSUN2-mediated m5C methylation of DOCK9 regulating vascular stability in brain arteriovenous malformationsGanglei Li, Hongfei Zhang, Biyun Wang, et al.
Journal of Neuro-Oncology|March 7, 2019
SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activationFei Liu, Christopher D Cox, Reshmi Chowdhury, et al.
Neuro-Oncology|March 15, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Julia Selfridge, Reema R Mody, et al.
Cell Metabolism|July 21, 2015
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR SignalingXudong Fu, Randall M Chin, Laurent Vergnes, et al.
Journal of the National Cancer Institute|September 5, 2012
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomasArthur P Chou, Reshmi Chowdhury, Sichen Li, et al.
Neuro-Oncology|January 19, 2013
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcomeShadi Lalezari, Arthur P Chou, Anh Tran, et al.
Pageof 10